Outsourcing-pharma11d
Ethris reports positive phase 1 results for asthma mRNA therapy
Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed ...
Outsourcing-pharma12d
Lantheus to acquire Evergreen in $1bn deal to expand radiopharmaceutical pipeline
Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a ...
Outsourcing-pharma13d
Manas AI bags $24.6 million to turbocharge drug discovery
The round was led by the US venture capital (VC) firm General Catalyst Partners with participation from compatriot VC Greylock Partners in addition to strategic investors. Manas will use the proceeds ...
Outsourcing-pharma13d
Women in Science: Émilie Barré on her passion for applying data to real-world challenges
Throughout her career, One2Treat’s Émilie Barré has focused on developing both the analytical and leadership aspects ...
Outsourcing-pharma13d
Novo Nordisk’s next-generation obesity drug shows promise in early clinical trials
Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...
Outsourcing-pharma18d
Arctic Therapeutics to tackle dementia and skin disease with €26.5 million series A
Arctic Therapeutics announced this week that it has raised €26.5 million, a sum bankrolled by investors including the European Innovation Council (EIC) Fund, the Icelandic investment firm Kaldbakur ...
Outsourcing-pharma18d
The largest pharma acquisitions of 2024
From Novo Holding’s purchase of Catalent to BMS’s Karuna acquisition, here are 10 of the most significant M&A moments last year Compared to the previous years, 2024 has been a relatively slow year for ...